GlassScriptPhysician profile
Mindy Valenti
NPI 1427571058
$3,546.81
in general payments reported to CMS, 2019-2025
19 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $585 · 2022: $1,016 · 2023: $884 · 2024: $641 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,945.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $815.25 | 2021-2024 | |
| Agile Therapeutics, INC. | $448.33 | 2021-2024 | Twirla |
| Organon LLC | $388.04 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $386.42 | 2022-2025 | |
| Avion Pharmaceuticals | $299.36 | 2021-2022 | |
| Evofem Biosciences, INC. | $295.72 | 2021-2025 | Phexxi, Solosec, Phexx |
| Biogen, INC. | $190.26 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $154.90 | 2023-2024 | Myfembree |
| Myovant Sciences INC. | $124.00 | 2022 | |
| Merck Sharp & Dohme LLC | $79.72 | 2023-2025 | Gardasil 9 |
| Exeltis, USA INC. | $72.55 | 2021-2024 | Slynd |
| Astellas Pharma US INC | $59.46 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $54.62 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.96 | 2023-2025 | |
| Medtronic, INC. | $45.26 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $35.14 | 2023 | Stratafix, Dermabond Prineo |
| Coopersurgical, INC. | $22.13 | 2023 | Paragard T 380a |
| Daiichi Sankyo INC. | $13.95 | 2021 | |
| Glaxosmithkline, LLC. | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindy Valenti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.